BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
EVR
Evercore Inc.
EVR has a slight edge over BAC overall, supported by stronger modeled upside and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EVR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
EVR's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like EVR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over EVR in the historical PE scenario, which offers more potential upside but is not a forecast.
EVR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $152 | -49% |
| Fair | 15x | $282 | -4.4% |
| Forward | 15x | $295 | — |
| Current | 16x | $295 | — |
| Expensive | 29x | $526 | +78% |
Historical ranges are pointers, not guarantees.
EVR's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
EVR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for EVR, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
EVR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.11 | +10% |
| Q3 2026 | $18.25 | +45% |
| Q2 2026 | $17.73 | +61% |
| Q1 2026 | $17.77 | +70% |
| Q4 2025 | $14.05 | +55% |
| Q3 2025 | $12.57 | +61% |
| Q2 2025 | $11.02 | +52% |
| Q1 2025 | $10.47 | +64% |
| Q4 2024 | $9.08 | +43% |
EVR has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over EVR on profitability, with a higher operating margin.
EVR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +12% |
| Q2 2026 | $990.2M | +19% |
| Q1 2026 | $1.4B | +100% |
| Q4 2025 | $1.3B | +32% |
| Q3 2025 | $1B | +41% |
| Q2 2025 | $833.8M | +21% |
| Q1 2025 | $694.8M | +20% |
| Q4 2024 | $975.3M | +24% |
EVR has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -0.1 points |
| Q2 2026 | 15% | -3.2 points |
| Q1 2026 | 24% | +7.7 points |
| Q4 2025 | 24% | +2.4 points |
| Q3 2025 | 21% | +4.2 points |
| Q2 2025 | 18% | +2.2 points |
| Q1 2025 | 16% | +1.2 points |
| Q4 2024 | 22% | +6.6 points |
EVR's operating margin was 21% last quarter, about level with the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
EVR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $640.8M | +18% |
| Q2 2026 | $514.8M | +25% |
| Q1 2026 | -$229M | +$340.3M |
| Q4 2025 | $798.6M | +19% |
| Q3 2025 | $541.5M | +139% |
| Q2 2025 | $411.7M | +21% |
| Q1 2025 | -$569.3M | -$287M |
| Q4 2024 | $673.1M | +63% |
EVR has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over EVR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EVR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -212K shares |
| 1 year | -3.5% | -1.5M shares |
| 3 years | +2.3% | +922K shares |
| 5 years | -4.2% | -1.8M shares |
| Available history | -5.3% | -2.3M shares |
EVR has 41M diluted shares, down 3.5% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EVR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
EVR has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EVR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 54.7 | Neutral |
EVR's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over EVR on valuation relative to its sector.
EVR PE vs Financial Services Sector
| Metric | EVR | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 24% above |
| PE % | 53 | 63 | 10 pts below |
EVR is trading at 16x earnings, a 24% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
EVR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $271.6 | 8.7% above |
| 20 week MA | $294.5 | 0.3% above |
| 50 week MA | $318.7 | 7.3% below |
| 100 week MA | $294.7 | 0.2% above |
| 200 week MA | $235.8 | 25% above |
EVR has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over EVR on returns for 2026, with the stronger performance.
EVR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $75.4 | $110.5 | +47% |
| 2021 | $110.5 | $135.7 | +23% |
| 2022 | $135.7 | $109.6 | -19% |
| 2023 | $109.6 | $171.1 | +56% |
| 2024 | $171.1 | $278.0 | +63% |
| 2025 | $278.0 | $352.2 | +27% |
| 2026 YTD | $352.2 | $295.3 | -16% |
EVR has finished higher in five of the last six years, two of them by more than 50%. It's down 16% so far in 2026.